In conclusion, promoter hypermethylation of SFRP3 is a frequent event in HCCs and epigenetic downregulation of SFRP3 mRNA may contribute to aberrant activation of Wnt/β-catenin in HCC. Here, FRZB is linked to hepatocellular carcinoma.